Skip to search formSkip to main contentSkip to account menu

TD-4208

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Revefenacin (TD‐4208) is a novel, long‐acting, and lung‐selective muscarinic cholinergic receptor (mAChR) antagonist in… 
Review
2017
Review
2017
ABSTRACT Introduction: Long acting muscarinic receptor antagonists (LAMA) reverse airflow obstruction by antagonizing para… 
2014
2014
Introduction TD-4208 is a lung-selective, LAMA shown to have a long duration of action and minimal systemic antimuscarinic… 
Review
2013
2013
2013
Tiotropium is currently the only once-daily, long-acting muscarinic antagonist (LAMA) approved in the United States and other… 
2012
2012
Background: TD-4208 is a potent and selective inhaled muscarinic antagonist with functional lung selectivity and long duration in…